Insulin Mutation Screening in 1,044 Patients With Diabetes
Diabetes2007Vol. 57(4), pp. 1034–1042
Citations Over TimeTop 1% of 2007 papers
Emma L. Edghill, Sarah E. Flanagan, Ann‐Marie Patch, Chris Boustred, Andrew Parrish, Beverley Shields, Maggie Shepherd, Khalid Hussain, Ritika R. Kapoor, Maciej T. Małecki, Michael J. MacDonald, Julie Støy, Donald F. Steiner, Louis H. Philipson, Graeme I. Bell, the Neonatal Diabetes International Collaborative Group, Andrew T. Hattersley, Sian Ellard
Abstract
We conclude that INS mutations are the second most common cause of PND and a rare cause of MODY. Insulin gene mutation screening is recommended for all diabetic patients diagnosed before 1 year of age.
Related Papers
- → Age at onset and different types of psoriasis(2006)139 cited
- → A novel KLF11 variant in a family with maturity‐onset diabetes of the young(2022)7 cited
- → <p>Maturity-Onset Diabetes of the Young Identified Among Algerian Probands with Early-Onset Diabetes</p>(2020)2 cited
- → Two case reports of maturity-onset diabetes of the young type 3 caused by the hepatocyte nuclear factor 1α gene mutation(2023)1 cited
- → A heterozygous mutation at promoter region of insulin gene (INS) accounts for early-onset diabetes: A case report and review of the literature(2023)